Beconase AQ

Beconase AQ is FDA-approved for:

• Treatment of Allergic Rhinitis: Including both seasonal (hay fever) and perennial (year-round) allergic rhinitis.
• Prevention of Nasal Polyps: Following surgical removal in patients with a history of recurrent nasal polyps.

Beconase AQ is contraindicated in patients with:

• Known hypersensitivity to beclomethasone dipropionate or any other components of the formulation.
• Untreated localized infections involving the nasal passages, such as herpes simplex.

Patients using Beconase AQ should be advised to:

• Use the nasal spray regularly, even if symptoms improve, to maintain control over allergic rhinitis or prevent nasal polyps.
• Rinse the mouth with water after using the spray to reduce the risk of developing oral thrush, a common side effect of inhaled corticosteroids.
• Report any persistent or worsening nasal symptoms, such as bleeding, crusting, or sores, to their healthcare provider.
• Be aware that it may take several days to a week to notice the full benefits of the medication.
• Store the bottle upright at room temperature and keep it out of the reach of children.

Common side effects of Beconase AQ may include:

• Nasal irritation or burning sensation
• Sneezing immediately after use
• Dryness or crusting in the nasal passages
• Sore throat or hoarseness
• Headache

Serious side effects, though rare, can include:

• Nasal Septum Perforation: Long-term use of corticosteroid nasal sprays can sometimes lead to thinning of the nasal septum, resulting in a perforation.
• Glaucoma or Cataracts: Long-term use of corticosteroids may increase the risk of developing these eye conditions.
• Systemic Effects: Although rare, corticosteroids can be absorbed into the bloodstream and cause effects like slowed growth in children, adrenal suppression, or decreased bone mineral density.

• Nasal Irritation and Bleeding: Beconase AQ can cause nasal irritation, dryness, and, in some cases, nosebleeds. Patients should avoid using the spray if they have active nasal sores or infections.
• Use in Children: Long-term use in children should be monitored by a healthcare provider due to the potential for growth suppression. Regular growth checks are recommended.
• Eye Health: Patients with a history of glaucoma or cataracts should be monitored regularly if using corticosteroid nasal sprays long-term.

Beconase AQ may interact with other medications, including:

• Systemic Corticosteroids: Using Beconase AQ with systemic corticosteroids can increase the risk of systemic side effects.
• Antifungal or Antiviral Medications: Such as ketoconazole or ritonavir, may increase the levels of corticosteroids in the blood, potentially leading to more side effects.

Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Alternative treatments for allergic rhinitis and nasal polyps include:

• Other Nasal Corticosteroids: Such as fluticasone (Flonase) or mometasone (Nasonex), which may be used for similar conditions.
• Antihistamine Nasal Sprays: Such as azelastine, which can provide quick relief from allergic symptoms.
• Saline Nasal Sprays: For nasal irrigation and to help keep the nasal passages moist.
• Oral Antihistamines: Such as loratadine or cetirizine, which may be used in conjunction with nasal sprays for better control of symptoms.

The choice of treatment depends on the severity of the condition, patient preferences, and response to previous treatments.